Cisplatin and drug design | 16–18 years
By Karen Marshall
Assess learners’ understanding of the mechanism of cisplatin as an anticancer drug with these examination-style questions.
Several post-16 exam specifications require learners to know why cisplatin prevents DNA replication and to be able to explain why such drugs can have adverse effects.
This resource reviews the action of cisplatin as an anticancer drug and explores the properties of transition metal complexes. Targeted at learners in the second year of a 16-18 course in chemistry, the resource consists of three parts.
Part 1 – exploring the structure of cisplatin using transition metal chemistry.
Part 2 – exploring the mechanism of cisplatin as an anticancer drug.
Part 3 – exploring other drugs in the platin family.